放疗剂量对颈段食管癌疗效的影响及预后因素分析
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

安徽省高等学校自然科学研究重点项目(KJ2019A0357);安徽省临床重点专科建设项目;蚌埠医学院研究生科研创新计划(BYYCX1967)


Effects of radiotherapy dose on cervical esophageal carcinoma and related prognosic factors analysis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察放疗剂量对颈段食管癌(cervical esophageal carcinoma,CEC)疗效的影响,并对CEC的预后因素进行分析。方法:回顾性分析2013—2018年收治的96例接受三维适形放疗或调强放疗的CEC患者,依据大体肿瘤放疗剂量分为低剂量组(≤60 Gy)、中剂量组(>60~<66 Gy)及高剂量组(≥66 Gy),比较各组临床疗效、急性不良反应及治疗失败模式的差异,并分析CEC患者的相关预后因素。结果:放疗结束后1个月观察近期疗效,3组的有效率分别为66.7%、85.4%、85.7%,差异无统计学意义(P=0.114);单因素分析显示放疗剂量是总生存(overall survival,OS)(P=0.031)、无进展生存(progression-free survival,PFS)(P=0.045)、无局部区域进展生存(local-regional failure-free survival,LRFFS)(P=0.020)的影响因素,中、高剂量组疗效无差异,且均较低剂量组好(P<0.05)。CEC OS的独立预后因素是放疗剂量、是否同步化疗及邻近器官是否受侵。结论:CEC采用根治性放化疗可获得较好疗效,中剂量即>60~<66 Gy可能是CEC更为合理的放疗剂量;放疗剂量、是否同步化疗及邻近器官是否受侵是CEC OS的独立预后因素。

    Abstract:

    Objective:To observe the effect of radiotherapy dose on cervical esophageall carcinoma,and to analyze the prognostic factors of cervical esophageal carcinoma. Methods:A retrospective analysis was performed on 96 patients with cervical esophageal carcinoma who received three dimensional conformal radiation therapy or intensity-modulated radiation therapy from 2013 to 2018 according to inclusion criteria. All the patients are divided into three groups according to the radiation dose of gross tumor:the low-dose group(≤60 Gy),the medium-dose group(>60~<66 Gy)and the high-dose group(≥66 Gy)respectively. The clinical effect,acute adverse effects,and treatment failure mode were compared among three groups,and the prognostic factors of cervical esophageal carcinoma were analyzed. Results:The short-term efficacy was observed one month after radiotherapy,and the objective response rate was 66.7%,85.4%,and 85.7%,respectively. There was no statistical difference among three groups(P=0.114). The univariate analysis showed that radiotherapy dose was the influencing factor of overall survival(P=0.031),progression-free survival(P=0.045)and local-regional failure-free survival(P=0.020),and there was no difference in the efficacy between the middle-dose group and the high-dose group,and all of them better than the low-dose group(P<0.05). The independent prognostic factors of OS for cervical esophageal carcinoma are radiotherapy dose,synchronous chemotherapy,and invasion of adjacent organs. Conclusion:Radical chemoradiotherapy is effective for cervical esophageal cancer,and the medium dose,i.e. >60~<66 Gy,may be a more reasonable radiotherapy dose for cervical esophageal cancer. Radiotherapy dose,concurrent chemotherapy and invasion of adjacent organs are independent prognostic factors of OS.

    参考文献
    相似文献
    引证文献
引用本文

刘 佳,崔 珍,孙巧玉,江 浩,李多杰,樊晓玓.放疗剂量对颈段食管癌疗效的影响及预后因素分析[J].南京医科大学学报(自然科学版),2021,(4):557-563

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2020-10-29
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2021-04-29
  • 出版日期: